Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.15, $0.04 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $47.9 million versus the consensus estimate of $55 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.